Document is current
Any future updates will be listed below
-
Authors
Singh, Dave https://orcid.org/0000-0001-8918-7075
Higham, Andrew
Mathioudakis, Alexander G.
Beech, Augusta
- License Information
-
More Information
Article History
Accepted: 8 April 2025
First Online: 20 May 2025
Declarations
:
: The authors did not receive any funding for this paper.
: DS has received personal fees from Adovate, Aerogen, Almirall, Apogee, Arrowhead, AstraZeneca, Bial, Boehringer Ingelheim, Chiesi, Cipla, CONNECT Biopharm, Covis, CSL Behring, DevPro Biopharma LCC, Elpen, Empirico, EpiEndo, Genentech, Generate Biomedicines, GlaxoSmithKline, Glenmark, Kamada, Kinaset Therapeutics, Kymera, Menarini, MicroA, OM Pharma, Orion, Pieris Pharmaceuticals, Pulmatrix, Revolo, Roivant Sciences, Sanofi, Synairgen, Tetherex, Teva, Theravance Biopharma, Upstream and Verona Pharma. AGM has received honoraria from GlaxoSmithKline and Sanofi and has received non-financial support from Verona pharma, all not related to this work. AH has received honoraria for lecturing from Chiesi. AB has no conflicts to declare.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: DS, AH, AM and AB contributed to writing and reviewing the manuscript. All authors read and approved the final manuscript.
